INS and diabetes mellitus: Furthermore, estrogen replacement therapy did not change HbA1c and insulin area under the OGTT curve in patients with diabetes [35, 36] or change glucose tolerance or glucose uptake by the hyperinsulinemiceuglycemic clamp in healthy postmenopausal women [15, 16].